Introduction: Medullary thyroid cancer (MTC) is the main cause of mortality in MEN2 patients. Genetic screening for RET proto-oncogene has allowed earlier diagnosis and treatment. Prophylactic total thyroidectomy (PTT) for MEN2 patients is conventionally done by open surgery. This literature review aims to evaluate the effectiveness of MIVAT and determine whether the same outcome could be achieved with fewer post-operative complications.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to European Journal of Surgical Oncology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2017 Published by Elsevier Inc.